Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPARFUMS INCIPAR · Entity 4092 | Director | August 14, 2023 | August 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPARFUMS INC
Report date August 14, 2023 · Filed August 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,000 |
Reported balance
After 2023-08-14 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2023-08-14 · Exercise / conversion · Acquired 1,000 · Balance 6,000 |
| Common StockSEC Table I · non-derivative | Direct | 7,125 |
Reported balance
After 2023-08-14 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2023-08-14 · Exercise / conversion · Acquired 1,125 · Balance 7,125 |
| Common StockSEC Table I · non-derivative | Direct | 7,875 |
Reported balance
After 2023-08-14 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2023-08-14 · Exercise / conversion · Acquired 750 · Balance 7,875 |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-08-14 · Exercise / conversion · Disposed 250 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-08-14 · Exercise / conversion · Disposed 250 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-08-14 · Exercise / conversion · Disposed 250 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-08-14 · Exercise / conversion · Disposed 250 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-08-14 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-08-14 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 0 |
Reported balance
After 2023-08-14 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-08-14 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
After 2023-08-14 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2023-08-14 · Exercise / conversion · Disposed 375 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
After 2023-08-14 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2023-08-14 · Exercise / conversion · Disposed 375 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2023-08-14 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 300 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2018 Filed Feb 2, 2018 22:55 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000824 · s108924_form4.xml · derivative · entry 17 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:55 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000824 · s108924_form4.xml · derivative · entry 16 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:55 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000824 · s108924_form4.xml · derivative · entry 15 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:55 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000824 · s108924_form4.xml · derivative · entry 14 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:30 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000153 · doc4_4525.xml · derivative · entry 13 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:30 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000153 · doc4_4525.xml · derivative · entry 12 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:30 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000153 · doc4_4525.xml · derivative · entry 11 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:30 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000153 · doc4_4525.xml · derivative · entry 10 Dyens Michel · CIK 0001618158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.